(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate

97%

Reagent Code: #233415
fingerprint
CAS Number 1361390-56-8

science Other reagents with same CAS 1361390-56-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 560.51 g/mol
Formula C₂₄H₂₈N₆O₁₀
badge Registry Numbers
MDL Number MFCD31657423
inventory_2 Storage & Handling
Storage -20°C, Sealed, Inert Gas

description Product Description

Used as an active pharmaceutical ingredient in targeted drug delivery systems, particularly in antibody-drug conjugates (ADCs). Its structure enables stable linkage between monoclonal antibodies and cytotoxic agents, allowing selective release of the drug in tumor tissues. The compound’s amide and ester functionalities support conjugation and controlled cleavage in physiological environments, enhancing therapeutic efficacy while minimizing systemic toxicity. Commonly applied in oncology research for developing next-generation chemotherapeutics with improved specificity and reduced side effects.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 25mg
10-20 days ฿20,070.00
inventory 50mg
10-20 days ฿34,100.00
(5S,8S,E)-2,5-Dioxopyrrolidin-1-yl 11-(2-amino-2-oxoethyl)-5,8-dimethyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadec-13-en-15-oate
No image available

Used as an active pharmaceutical ingredient in targeted drug delivery systems, particularly in antibody-drug conjugates (ADCs). Its structure enables stable linkage between monoclonal antibodies and cytotoxic agents, allowing selective release of the drug in tumor tissues. The compound’s amide and ester functionalities support conjugation and controlled cleavage in physiological environments, enhancing therapeutic efficacy while minimizing systemic toxicity. Commonly applied in oncology research for deve

Used as an active pharmaceutical ingredient in targeted drug delivery systems, particularly in antibody-drug conjugates (ADCs). Its structure enables stable linkage between monoclonal antibodies and cytotoxic agents, allowing selective release of the drug in tumor tissues. The compound’s amide and ester functionalities support conjugation and controlled cleavage in physiological environments, enhancing therapeutic efficacy while minimizing systemic toxicity. Commonly applied in oncology research for developing next-generation chemotherapeutics with improved specificity and reduced side effects.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...